Case 1:18-cv-11553-RMB-KMW Document 3 Filed 09/07/18 Page 1 of 5 PageID: 740
`
`Keith I. Miller, Esq.
`ROBINSON MILLER LLC
`One Newark Center, 19th Floor
`Newark, NJ 07102
`Telephone: (973) 690-5400
`kmiller@rwmlegal.com
`
`Attorneysfor Plaintiffs Genentech, Inc.,
`Biogen, Inc., Hoffinann-La Roche Inc., and
`City ofHope
`
`Liza M. Walsh
`WALSH PIZZI O’REILLY FALANGA LLP
`One Riverfront Plaza
`Newark, NJ 07102
`Telephone: 973-757-1100
`lwalsh@walsh.law
`
`Attorneysfor Defendants Ceiltrion, Inc.,
`Ceiltrion Healthcare Co., Ltd., Teva
`Pharmaceuticals USA, Inc. and Teva
`Pharmaceuticals International GmbH
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`GENENTECH, INC., a Delaware corporation, Case No. 1:1 8-cv-00574 (RMB) (KMW)
`et al.,
`
`Honorable Renée M. Bumb, U.S.D.J.
`
`Plaintiffs,
`
`V.
`
`CELLTRION, NC., a Korean corporation, et
`al.,
`
`Defendants.
`
`GENENTECH, NC., a Delaware corporation, Case No. 1:1 8-cv- 11553 (RMB) (KMW)
`et al
`
`Honorable Renée M. Bumb, U.S.D.J.
`
`Plaintiffs,
`
`V.
`
`CELLTRION, INC., a Korean corporation, et
`al.,
`
`Defendants.
`
`STIPULATION AND CONSENT ORDER
`FOR CONSOLIDATION FOR ALL PURPOSES
`
`
`
`Keith I. Miller, Esq.
`ROBINSON MILLER LLC
`One Newark Center, 19th Floor
`Newark, NJ 07102
`Telephone: (973) 690-5400
`kmiller@rwmlegal.com
`
`Attorneysfor Plaintiffs Genentech, Inc.,
`Biogen, Inc., Hoffinann-La Roche Inc., and
`City ofHope
`
`Liza M. Walsh
`WALSH PIZZI O’REILLY FALANGA LLP
`One Riverfront Plaza
`Newark, NJ 07102
`Telephone: 973-757-1100
`lwalsh@walsh.law
`
`Attorneysfor Defendants Ceiltrion, Inc.,
`Ceiltrion Healthcare Co., Ltd., Teva
`Pharmaceuticals USA, Inc. and Teva
`Pharmaceuticals International GmbH
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`GENENTECH, INC., a Delaware corporation, Case No. 1:1 8-cv-00574 (RMB) (KMW)
`et al.,
`
`Honorable Renée M. Bumb, U.S.D.J.
`
`Plaintiffs,
`
`V.
`
`CELLTRION, NC., a Korean corporation, et
`al.,
`
`Defendants.
`
`GENENTECH, NC., a Delaware corporation, Case No. 1:1 8-cv- 11553 (RMB) (KMW)
`et al
`
`Honorable Renée M. Bumb, U.S.D.J.
`
`Plaintiffs,
`
`V.
`
`CELLTRION, INC., a Korean corporation, et
`al.,
`
`Defendants.
`
`STIPULATION AND CONSENT ORDER
`FOR CONSOLIDATION FOR ALL PURPOSES
`
`
`
`Case 1:18-cv-11553-RMB-KMW Document 3 Filed 09/07/18 Page 2 of 5 PageID: 741
`
`WHEREAS, on January 12, 201$, Plaintiffs Genentech, Inc., Biogen, Inc., Hoffmann-La
`
`Roche Inc., and City of Hope (collectively, “Plaintiffs”) filed suit against Defendants Ceiltrion,
`
`Inc., Ceiltrion Healthcare Co., Ltd., Teva Pharmaceuticals USA, and Teva Pharmaceuticals
`
`International GmbH (collectively “Defendants”) in Genentech, Inc., et il. v. Cetttrion, Inc., et al.,
`
`No. 1:1 8-cv-574 (RIvifi) (KMW) (the “Lead Action”) asserting claims of infringement and
`
`declaratory relief regarding forty (40) patents in connection with Defendants’ filing of an
`
`Abbreviated Biologic License Application (“aBLA”) for approval to market a biosimilar version
`
`of Plaintiffs’ medicinal product, Rituxan®;
`
`WHEREAS, in the Lead Action, Plaintiffs filed an Amended Complaint on July 5, 2018,
`
`reducing the number of asserted patents to eighteen (18);
`
`WHEREAS,
`
`in light of Defendants’ contention that the parties had satisfied certain
`
`exchanges required by 42 U.S.C. § 262(l)(5) on June 11, 2018, on July 11, 2018, Plaintiffs filed,
`
`out of an abundance of caution and reserving all rights, a related suit against Defendants in
`
`Genentech, Inc., et a!. v. Cetlfrion, Inc., et at., No. l:18-cv-1 1553 (RIvifi) (KvIW) (the “Related
`
`Action”) asserting the same claims on the same eighteen (1$) patents as in the Lead Action;
`
`WHEREAS, both the Lead Action, as reflected in the Amended Complaint, and the Related
`
`Action concern the same parties, the same product, and the same patents;
`
`WBEREAS, counsel for all parties in the Lead Action and the Related Action having
`
`consented to the consolidation of those actions for all purposes, including trial, and the Court
`
`having found that consolidating those actions would promote convenience and economy in judicial
`
`administration and that consolidating these actions would conserve the parties’ and the Court’s
`
`resources; and good cause having been shown for the entry of this Order,
`
`IT IS on this
`
`day of September, 2018
`
`
`
`Case 1:18-cv-11553-RMB-KMW Document 3 Filed 09/07/18 Page 3 of 5 PageID: 742
`
`ORDERED THAT:
`
`1.
`
`The following cases are consolidated for all purposes, including trial, pursuant to
`
`Federal Rule of Civil Procedure 42(a): Genentech, Inc., et at. v. Celitrion, Inc., et al., No. 1:1 8-cv-
`
`574 (RMB) (KMW) and Genentech, Inc., et at. v. Celttrion, Inc., et at., No. 1:1 $-cv-l 1553 (RIV1B)
`
`(KMW).
`
`2.
`
`Plaintiffs’ complaint, filed on July 11, 2018, in the Related Action shall be deemed
`
`served as of the date of this Order.
`
`3.
`
`Defendants’ Answer, Affirmative Defenses, and Counterclaims to Plaintiffs’
`
`Amended Complaint, filed on August 2, 2018, in the Lead Action (Dkt. No. 73) shall be deemed
`
`to apply to the Related Action as of the date of this Order.
`
`4.
`
`Plaintiffs’ Motion to Dismiss Defendants’ Counterclaims, filed on July 16, 2018,
`
`in the Lead Action (Dkt. No. 57) shall be deemed to apply to Defendants’ Counterclaims filed on
`
`August 2, 2018, as those Counterclaims apply to the Related Action by Item 3, above, as of the
`
`date of this Order.
`
`5.
`
`Any future filings in the consolidated actions are to be made under the Lead Action,
`
`case number 1:1 8-cv-574.
`
`6.
`
`All filings, discovery, and Court orders entered to-date in the Lead Action shall
`
`apply as if made or entered in the Related Action.
`
`7.
`
`All discovery obtained in the Lead Action shall be available for use in the Related
`
`Action and vice versa for the purpose of prosecuting, defending, or settling either action, to the
`
`extent such discovery is otherwise admissible and subject to the terms of the Stipulated Discovery
`
`Confidentiality Order.
`
`
`
`Case 1:18-cv-11553-RMB-KMW Document 3 Filed 09/07/18 Page 4 of 5 PageID: 743
`
`8.
`
`The parties’ Joint Discovery Plan submitted in the Lead Action shall apply to the
`
`Related Action.
`
`SO ORDERED.
`
`!Lr
`
`Honkenée M. Bumb, U.S.D.J.
`
`ROBINSON MILLER LLC
`
`WALSH PIZZI O’REILLY FALANGA LLP
`
`By:
`
`s/Keith I Miller
`
`Keith I. Miller
`One Newark Center, 19th floor
`Newark, NJ 07102
`Telephone: 973-690-5400
`lcmiller@rwmlegal.com
`
`OF COUNSEL:
`
`David I. Gindler
`Gary N. ftischling
`Keith A. Orso
`IRELL & MANELLA LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, CA 90067
`Telephone: (310) 277-1010
`
`Attorneysfor Plaintzffs Genentech, Inc.,
`Biogen, Inc., Hoffinann-La Roche Inc., and
`City ofHope
`
`By:
`
`s/Liza li Walsh
`
`Liza M. Walsh
`One Riverfront Plaza
`Newark, NJ 07102
`Telephone: 973-757-1100
`lwalsh@walsh.law
`
`Of COUNSEL:
`
`Elaine Herrmann Blais
`Daryl L. Wiesen
`Alexandra Lu
`GooDwiN PRocTER LLP
`100 Northern Avenue
`Boston, MA 02210
`(617) 570-1000
`
`Cynthia Lambert Hardman
`GooDwiN PROCTER LLP
`620 8th Avenue
`New York, NY 10018
`212-813-8800
`
`Natasha E. Daughtrey
`GooDwiN PRocTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`213-426-2500
`
`
`
`Case 1:18-cv-11553-RMB-KMW Document 3 Filed 09/07/18 Page 5 of 5 PageID: 744
`
`Michelle S. Rhyu
`COOLEY LLP
`3175 Hanover Street
`Palo Alto, CA 94304
`(650) 8435000
`
`Eamonn Gardner
`COOLEY LLP
`4401 Eastgate Mall
`San Diego, CA 92121
`(858) 550-6000
`
`Attorneysfor Defendants Cetitrion, Inc.,
`Cellfrion Healthcare Co., Ltd., Teva
`Pharmaceuticals USA, Inc. and Teva
`Pharmaceuticals International GmbH
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
